Early Intervention With Rituximab May Benefit Patients With New-Onset Generalized MG Based on the results of the RINOMAX trial, early intervention with rituximab treatment may benefit patients with new-onset MG.

Early treatment with #Rituximab may provide better outcomes for patients with new-onset generalized #MyastheniaGravis (MG), according to the long-term follow-up results of the #RINOMAX clinical trial published in the @europeanjournalofneurology.ean.org

Read more: https://bit.ly/47G1Krl

#MedSky